Huntington National Bank’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7K | Sell |
974
-38
| -4% | -$533 | ﹤0.01% | 1695 |
|
|
2025
Q1 | $15.8K | Buy |
1,012
+7
| +0.7% | +$109 | ﹤0.01% | 1598 |
|
|
2024
Q4 | $14K | Buy |
1,005
+36
| +4% | +$501 | ﹤0.01% | 1649 |
|
|
2024
Q3 | $9.01K | Sell |
969
-133
| -12% | -$1.24K | ﹤0.01% | 1796 |
|
|
2024
Q2 | $10.2K | Sell |
1,102
-35
| -3% | -$326 | ﹤0.01% | 1684 |
|
|
2024
Q1 | $11.3K | Buy |
1,137
+10
| +0.9% | +$99 | ﹤0.01% | 1649 |
|
|
2023
Q4 | $3.64K | Sell |
1,127
-75
| -6% | -$242 | ﹤0.01% | 1965 |
|
|
2023
Q3 | $6.38K | Buy |
1,202
+14
| +1% | +$74 | ﹤0.01% | 1723 |
|
|
2023
Q2 | $11.3K | Buy |
1,188
+219
| +23% | +$2.09K | ﹤0.01% | 1534 |
|
|
2023
Q1 | $10.7K | Sell |
969
-22
| -2% | -$242 | ﹤0.01% | 1507 |
|
|
2022
Q4 | $14.7K | Buy |
+991
| New | +$14.7K | ﹤0.01% | 1378 |
|